GlassScriptPhysician profile
James Bryan Meiling
NPI 1669933347
$717.06
in general payments reported to CMS, 2019-2025
8 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $84.52 · 2021: $90.34 · 2023: $240 · 2024: $111 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $255.62 | 2023-2025 | Spinraza, Skyclarys, Qalsody |
| Checkpoint Surgical, INC | $122.99 | 2025 | Checkpoint Stimulators |
| Ns Pharma, INC. | $103.97 | 2023 | Viltepso |
| Medtronic, INC. | $90.34 | 2021 | |
| Saol Therapeutics INC. | $44.01 | 2020 | |
| Merz North America, INC. | $40.51 | 2020 | |
| Cadwell Industries, INC | $37.57 | 2025 | |
| Alexion Pharmaceuticals, INC. | $22.05 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Meiling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.